CAPR · Capricor Therapeutics, Inc.

$9.38 +0.10 (+1.08%)

Russell 2000 member Rebalance outlook locked

Market Cap

$574.99M

58.14M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Linda Marban	Chief Executive Officer	$150,000	$45,000	—	$1,460,532	—	$1,500	$1,657,032
Anthony "A.J." Bergmann	Chief Financial Officer	$287,500	$27,500	—	$475,692	—	$1,500	$792,192
Karen G. Krasney	Executive Vice President & General Counsel	$313,750	$31,500	—	$415,855	—	$1,500	$762,605

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen G. Krasney	Executive Vice President & General Counsel	$300,000	—	—	$38,827	—	$1,500	$340,327
Anthony "A.J." Bergmann	Chief Financial Officer	$212,500	—	—	$38,827	—	$1,500	$252,827
Linda Marban	Chief Executive Officer	$156,909	—	—	$70,510	—	$1,500	$228,919

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Linda Marban	Chief Executive Officer ^^	$232,909	—	—	$144,562	—	—	$377,471
Karen G. Krasney	Executive Vice President & General Counsel ^^	$300,000	—	—	$50,890	—	$1,000	$351,890
Anthony "A.J." Bergmann	Chief Financial Officer	$200,000	—	—	$72,700	—	$1,000	$273,700

Key facts CIK 1133869 CUSIP 14070B309 13F (30d) 150 filings 150 filers Visit website Investor relations